Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder
Clinical trial NCT01414114 · COMPLETED
Trial details
- NCT number
- NCT01414114
- Sponsor
- KAI Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-05
- Primary completion
- 2012-05-21
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.